Quote:
Originally Posted by Tmarkwald
|
Interesting study. I wonder if they will do the "salvage" study as well.
For example, the two main chemotherapy regimens for advanced Hodgkin's are MOPP and ABVD. Both are 90+% effective alone. When both regimens are given simultaneously, they are 96% effective. But, if you let the patient fail on one of them and then start the other, you get 99% efficacy. So sometimes more all at once is not better